InnoCan Pharma Corporation
INNO
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.23M | -1.58M | -649.00K | -1.83M | -2.60M |
| Total Depreciation and Amortization | 36.00K | 34.00K | 35.00K | 35.00K | 37.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.25M | 2.02M | 1.36M | 1.87M | 2.17M |
| Change in Net Operating Assets | 521.00K | -926.00K | -1.21M | -1.65M | -1.99M |
| Cash from Operations | 572.00K | -453.00K | -464.00K | -1.58M | -2.39M |
| Capital Expenditure | -14.00K | -16.00K | -18.00K | -15.00K | -20.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 69.00K | 69.00K | 70.00K | 69.00K | 0.00 |
| Cash from Investing | 55.00K | 53.00K | 52.00K | 54.00K | -20.00K |
| Total Debt Issued | 640.00K | 640.00K | 640.00K | -- | -- |
| Total Debt Repaid | -17.00K | -20.00K | -21.00K | -22.00K | -21.00K |
| Issuance of Common Stock | 93.00K | 488.00K | 395.00K | 1.01M | 1.60M |
| Repurchase of Common Stock | -123.00K | -123.00K | -123.00K | -123.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 953.00K | 1.42M | 1.36M | 1.84M | 1.85M |
| Cash from Financing | 1.55M | 2.41M | 2.25M | 2.70M | 3.42M |
| Foreign Exchange rate Adjustments | 40.00K | 58.00K | -68.00K | -56.00K | 17.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.21M | 2.07M | 1.77M | 1.12M | 1.03M |